Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 12:16 pm Purchase |
2023-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,778,188 9.500% |
213,089 (+3.83%) |
Filing History |
| 2024-02-13 12:13 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,463,641 9.990% |
491,981 (+9.90%) |
Filing History |
| 2024-02-13 12:08 pm Purchase |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,518,881 8.900% |
1,244,078 (+29.10%) |
Filing History |
| 2024-02-13 12:00 pm Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,774,389 9.990% |
1,363,179 (+39.96%) |
Filing History |
| 2024-02-13 11:55 am Purchase |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT, LLC | 716,759 9.900% |
366,333 (+104.54%) |
Filing History |
| 2024-02-13 11:50 am Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,435,974 5.000% |
85,641 (+3.64%) |
Filing History |
| 2024-02-13 11:44 am Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 9.500% |
2,388,851 (+69.28%) |
Filing History |
| 2024-02-05 4:43 pm Purchase |
2024-01-26 | 13G | Cogent Biosciences, Inc. COGT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,481,034 6.400% |
5,481,034 (New Position) |
Filing History |
| 2023-10-30 5:03 pm Purchase |
2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 9,592,212 9.990% |
9,592,212 (New Position) |
Filing History |
| 2023-10-30 5:02 pm Purchase |
2023-10-18 | 13G | 89bio, Inc. ETNB |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,808,374 6.400% |
4,808,374 (New Position) |
Filing History |
| 2023-06-15 4:31 pm Purchase |
2023-06-05 | 13G | Zura Bio Limited ZURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,850,000 6.600% |
2,850,000 (New Position) |
Filing History |
| 2023-04-24 4:47 pm Purchase |
2023-04-12 | 13G | InflaRx N.V. IFRX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,733,910 10.300% |
3,587,670 (+167.16%) |
Filing History |
| 2023-04-18 4:16 pm Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 177,660 9.990% |
-194,617 (-52.28%) |
Filing History |
| 2023-03-10 5:15 pm Purchase |
2023-01-25 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,379 5.300% |
724,077 (+67.53%) |
Filing History |
| 2023-02-13 4:37 pm Purchase |
2022-12-31 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,280,175 10.200% |
10,875 (+0.17%) |
Filing History |
| 2023-02-13 1:44 pm Unchanged |
2022-12-31 | 13G | Disc Medicine, Inc. IRON |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 1:31 pm Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,848,938 5.700% |
8,600 (+0.22%) |
Filing History |
| 2023-02-13 1:21 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 36,822,190 5.900% |
-8,888,145 (-19.44%) |
Filing History |
| 2023-02-13 1:07 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,376,815 9.300% |
2,804,396 (+78.50%) |
Filing History |
| 2023-02-13 12:36 pm Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-2,230,250 (Position Closed) |
Filing History |